1. Complement and Cancer—A Dysfunctional Relationship?
   Joshua M. Thurman et al, 2020, Antibodies CrossRef
2. Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome
   Olga Kuźmycz et al, 2020, Cancer Biology & Therapy CrossRef
3. Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer
   Srinivas Dash et al, 2022, Cancers CrossRef
4. Innate immune mediators in cancer: between defense and resistance
   Pedro Berraondo et al, 2016, Immunological Reviews CrossRef
5. Membrane-Bound Complement Regulatory Proteins in Breast Cancer: Are They Best Therapeutic Targets?
   Sofia Álvarez-Lorenzo et al, 2023, Breast Cancer Updates CrossRef
6. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer
   Shuai Xue et al, 2021, Frontiers in Immunology CrossRef
7. Complement in Metastasis: A Comp in the Camp
   Daniel Ajona et al, 2019, Frontiers in Immunology CrossRef
8. An update on the role of complement in hepatocellular carcinoma
   Zhijie Xiao et al, 2022, Frontiers in Immunology CrossRef
9. Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis
   Juan Huang et al, 2020, Cancer Cell International CrossRef
10. Importance of antibody isotypes in antitumor immunity by monocytes and complement using human‐immune tumor models
    Sandra Lara et al, 2021, European Journal of Immunology CrossRef
11. An Immunoregulatory Role for Complement Receptors in Murine Models of Breast Cancer
    Fazrena Nadia Md Akhir et al, 2021, Antibodies CrossRef
12. Coenzyme Q10 attenuates rat hepatocarcinogenesis via the reduction of CD59 expression and phospholipase D activity
    Mahmoud Abdel‐Latif et al, 2020, Cell Biochemistry and Function CrossRef
13. Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1
    A Abdelbaset-Ismail et al, 2017, Leukemia CrossRef
14. Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59
    Ronghua Zhang et al, 2019, Cell Death & Disease CrossRef
15. UBXN1 maintains ER proteostasis and represses UPR activation by modulating translation
    Brittany A Ahlstedt et al, 2024, EMBO Reports CrossRef
16. Therapy‐induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression
    Anas HA Abu‐Humaidan et al, 2024, Immunology & Cell Biology CrossRef
17. The role of the complement system in cancer etiology and management
    Stefan E. Sonderegger et al, 2024, Clinical Immuno-Oncology CrossRef
18. The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis
    Silvio Bandini et al, 2016, OncoImmunology CrossRef
19. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention
    Zvi Fishelson et al, 2019, Frontiers in Immunology CrossRef
20. Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway
    Yanfei Jia et al, 2019, Cancer Cell International CrossRef
21. C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2
    Jie Xiong et al, 2021, Cancer Gene Therapy CrossRef
22. The dynamics of humoral immunity factors in rats under experimental BLV infection
    E S Krasnikova et al, 2021, IOP Conference Series: Earth and Environmental Science CrossRef